Cold Chain Products for Plasma Fractionation Market Report: Trends, Forecast and Competitive Analysis to 2030

Cold Chain Products For Plasma Fractionation Trends and Forecast

The future of the global cold chain products market for plasma fractionation looks promising with opportunities in the blood collection center and blood component provider, hospital and transfusion center, and clinical research laboratorie markets. The global cold chain products market for plasma fractionation is expected to reach an estimated $700 million by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increasing use of immunoglobulins and other plasma products, growing need for plasma-based medicines to treat chronic conditions, and on-going advancement in refrigeration equipment and systems.

A more than 150-page report is developed to help in your business decisions.

Cold Chain Products For Plasma Fractionation by Segment

The study includes a forecast for the global cold chain products for plasma fractionation by type, end use, and region.

Cold Chain Products Market for Plasma Fractionation by Type [Shipment Analysis by Value from 2018 to 2030]:

• Ultra-low temperature freezer
• Plasma freezer
• Temperature monitoring devices
• Plasma contact shock freezer
• Blood transport boxes
• Ice-lined refrigerator
• Others

Cold Chain Products Market for Plasma Fractionation by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Blood collection centers and blood component providers
• Hospitals and transfusion centers
• Clinical research laboratories
• Others

Cold Chain Products Market for Plasma Fractionation by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Cold Chain Products Companies for Plasma Fractionation

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cold chain products companies for plasma fractionation cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cold chain products for plasma fractionation companies profiled in this report include-

• B Medical Systems
• Blue Star
• Thermo Fisher Scientific
• Godrej And Boyce
• Haier Biomedical
• Eppendorf
• Avantor
• Biolife Solutions

Cold Chain Products for Plasma Fractionation Market Insights

Lucintel forecasts that temperature monitoring device is expected to witness highest growth over the forecast period.

Blood collection center and blood component provider will remain the largest segment due to increasing number of diseases like hemophilia and immune deficiency disorders as well as liver diseases and rising aging population.

North America will remain the largest segment over the forecast period due to increasing demand of plasma freezer demand and availability of advanced cold storage equipment for laboratories in the region.

Features of the Global Cold Chain Products Market for Plasma Fractionation

Market Size Estimates: Cold chain products market for plasma fractionation size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cold chain products market for plasma fractionation size by type, end use, and region. in terms of value ($M).

Regional Analysis: Cold chain products market for plasma fractionation breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and region.s for the cold chain products market for plasma fractionation.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cold chain products market for plasma fractionation.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the cold chain products market for plasma fractionation size?

Answer: The global cold chain products market for plasma fractionation is expected to reach an estimated $700 million by 2030.

Q.2. What is the growth forecast for cold chain products market for plasma fractionation?

Answer: The global cold chain products market for plasma fractionation is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the cold chain products market for plasma fractionation?

Answer: The major drivers for this market are increasing use of immunoglobulins and other plasma products, growing need for plasma-based medicines to treat chronic conditions, and on-going advancement in refrigeration equipment and systems.

Q.4. What are the major segments for cold chain products market for plasma fractionation?

Answer: The future of the global cold chain products market for plasma fractionation looks promising with opportunities in the blood collection center and blood component provider, hospital and transfusion center, and clinical research laboratorie markets.

Q.5. Who are the key cold chain products market for plasma fractionation companies?

Answer: Some of the key cold chain products for plasma fractionation companies are as follows:

• B Medical systems
• Blue Star
• Thermo Fisher Scientific
• Godrej and Boyce
• Haier Biomedical
• Eppendorf
• Avantor
• Biolife Solutions

Q.6. Which cold chain products market for plasma fractionation segment will be the largest in future?

Answer: Lucintel forecasts that temperature monitoring device is expected to witness highest growth over the forecast period.

Q.7. In cold chain products market for plasma fractionation, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to increasing demand of plasma freezer demand and availability of advanced cold storage equipment for laboratories in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cold chain products market for plasma fractionation by type (ultra-low temperature freezer, plasma freezer, temperature monitoring devices,plasma contact shock freezer, blood transport boxes, ice-lined refrigerator, and others), end use (blood collection centers and blood component providers, hospitals and transfusion centers, clinical research laboratories, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?